Prolonged Benefits of Thrombectomy for Large Vessel Occlusive Strokes

Follow-up to 1 year in a randomized trial supports sustained benefits in functional independence and quality of life.

Several trials have been published in the last 2 years showing that endovascular thrombectomy (EVT) with stent retriever devices improves outcomes for patients with large vessel occlusion (LVO) ischemic strokes. These trials have evaluated patient outcomes for 90 days following the initial event. Whether EVT has more prolonged benefit is unclear.

The investigators from the REVASCAT trial analyzed neurologic outcomes and quality of life in patients up to 1 year following stroke onset. The analysis was funded by an unrestricted manufacturer's grant. Patients were enrolled in the trial if they had a distal carotid or proximal middle cerebral artery occlusion and if they could be treated within 8 hours of stroke onset. The primary outcome was a …

Reviewing Author

Seemant Chaturvedi, MD

Disclosures

Consultant/Advisory BoardBayer Pharmaceuticals; Novartis

Grant/Research SupportNational Institute of Neurological Disorders and Stroke

Editorial BoardsNeurology; Stroke

Seemant Chaturvedi, MD

Disclosures

Consultant/Advisory BoardBayer Pharmaceuticals; Novartis

Grant/Research SupportNational Institute of Neurological Disorders and Stroke

Editorial BoardsNeurology; Stroke

Prolonged Benefits of Thrombectomy for Large Vessel Occlusive Strokes

Topics

Reviewing Author